Medicazione a base d’argento nella gestione dell’emergenza cutanea

Introduction: Exit-site (ES) and tunnel infections are the main infectious complication in peritoneal dialysis (PD); they also are risk factors for the development of peritonitis, for catheter removal and for dialysis drop-out. Up to now, besides the recommendations of the Guidelines there is no un...

Full description

Bibliographic Details
Main Authors: Walter Lunardi, Sonia Bianchi
Format: Article
Language:Italian
Published: AboutScience Srl 2021-09-01
Series:Giornale di Clinica Nefrologia e Dialisi
Subjects:
Online Access:https://journals.aboutscience.eu/index.php/gcnd/article/view/2296
_version_ 1798027660731875328
author Walter Lunardi
Sonia Bianchi
author_facet Walter Lunardi
Sonia Bianchi
author_sort Walter Lunardi
collection DOAJ
description Introduction: Exit-site (ES) and tunnel infections are the main infectious complication in peritoneal dialysis (PD); they also are risk factors for the development of peritonitis, for catheter removal and for dialysis drop-out. Up to now, besides the recommendations of the Guidelines there is no uniformity, nor on the classification, nor on the treatment strategies of the infected ES. Recent experiences are reported with alternative types of dressings that aim to reduce the incidence of ES infection and consequently of the subcutaneous tunnel. Methods: The Tuscan group conducted a retrospective observational study of 10 patients on PD who, showing signs of a suspected but not ascertained infection (negative microbiological culture), such as redness, edema, secretion, scab, had been medicated with silver-ions releasing Exit-Pad Ag. The aim was to evaluate and classify the evolution of ES lesions, in order to confirm the preventive efficacy of the silver-ions releasing dressing compared to the traditional ones. Results: After 4 weeks of treatment with Exit Pad Ag maintained in situ for 72 h, 6 patients no longer had any signs of inflammation. In 2 cases, several weeks of treatment were necessary to achieve a complete recovery, while in 2 other cases the signs of inflammation became negative in less time (2 weeks, 1 week). Conclusions: With the utilization of an alternative dressing such as Exit-Pad Ag on PD patients showing early signs of inflammation, the onset of a true infection can be prevented, with a progressive improvement of the ES.
first_indexed 2024-04-11T18:55:10Z
format Article
id doaj.art-5f48e414dcbb4137b82e593c1077b118
institution Directory Open Access Journal
issn 2705-0076
language Italian
last_indexed 2024-04-11T18:55:10Z
publishDate 2021-09-01
publisher AboutScience Srl
record_format Article
series Giornale di Clinica Nefrologia e Dialisi
spelling doaj.art-5f48e414dcbb4137b82e593c1077b1182022-12-22T04:08:12ZitaAboutScience SrlGiornale di Clinica Nefrologia e Dialisi2705-00762021-09-013310.33393/gcnd.2021.2296Medicazione a base d’argento nella gestione dell’emergenza cutaneaWalter Lunardi0Sonia Bianchi1Ospedale SS Cosma e Damiano, Centro Dialisi Peritoneale, Pescia (PT) - ItalyOspedale degli Infermi, Centro Dialisi Peritoneale, San Miniato (PI) - ItalyIntroduction: Exit-site (ES) and tunnel infections are the main infectious complication in peritoneal dialysis (PD); they also are risk factors for the development of peritonitis, for catheter removal and for dialysis drop-out. Up to now, besides the recommendations of the Guidelines there is no uniformity, nor on the classification, nor on the treatment strategies of the infected ES. Recent experiences are reported with alternative types of dressings that aim to reduce the incidence of ES infection and consequently of the subcutaneous tunnel. Methods: The Tuscan group conducted a retrospective observational study of 10 patients on PD who, showing signs of a suspected but not ascertained infection (negative microbiological culture), such as redness, edema, secretion, scab, had been medicated with silver-ions releasing Exit-Pad Ag. The aim was to evaluate and classify the evolution of ES lesions, in order to confirm the preventive efficacy of the silver-ions releasing dressing compared to the traditional ones. Results: After 4 weeks of treatment with Exit Pad Ag maintained in situ for 72 h, 6 patients no longer had any signs of inflammation. In 2 cases, several weeks of treatment were necessary to achieve a complete recovery, while in 2 other cases the signs of inflammation became negative in less time (2 weeks, 1 week). Conclusions: With the utilization of an alternative dressing such as Exit-Pad Ag on PD patients showing early signs of inflammation, the onset of a true infection can be prevented, with a progressive improvement of the ES.https://journals.aboutscience.eu/index.php/gcnd/article/view/2296Exit-siteInfectionPreventionSilver
spellingShingle Walter Lunardi
Sonia Bianchi
Medicazione a base d’argento nella gestione dell’emergenza cutanea
Giornale di Clinica Nefrologia e Dialisi
Exit-site
Infection
Prevention
Silver
title Medicazione a base d’argento nella gestione dell’emergenza cutanea
title_full Medicazione a base d’argento nella gestione dell’emergenza cutanea
title_fullStr Medicazione a base d’argento nella gestione dell’emergenza cutanea
title_full_unstemmed Medicazione a base d’argento nella gestione dell’emergenza cutanea
title_short Medicazione a base d’argento nella gestione dell’emergenza cutanea
title_sort medicazione a base d argento nella gestione dell emergenza cutanea
topic Exit-site
Infection
Prevention
Silver
url https://journals.aboutscience.eu/index.php/gcnd/article/view/2296
work_keys_str_mv AT walterlunardi medicazioneabasedargentonellagestionedellemergenzacutanea
AT soniabianchi medicazioneabasedargentonellagestionedellemergenzacutanea